162 related articles for article (PubMed ID: 34927279)
41. The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome.
Liu Z; Wu X; Hwang ST; Liu J
Ann Dermatol; 2021 Dec; 33(6):487-496. PubMed ID: 34858000
[TBL] [Abstract][Full Text] [Related]
42. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
Fivenson DP; Hanson CA; Nickoloff BJ
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
44. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
45. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
[TBL] [Abstract][Full Text] [Related]
46. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.
Hsi AC; Lee SJ; Rosman IS; Carson KR; Kelley A; Viele V; Pang X; Musiek A; Schaffer A
J Am Acad Dermatol; 2015 Jan; 72(1):159-67. PubMed ID: 25440432
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
Vij A; Duvic M
Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
[TBL] [Abstract][Full Text] [Related]
48. Mitigation strategies among cutaneous T-cell lymphoma patients with positive
Allen PB; Goyal S; Switchenko J; Tarabadkar E; Pouch S; Parikh P; Palmer A; Martini D; Kim E; Lechowicz MJ
Leuk Lymphoma; 2023 Mar; 64(3):597-604. PubMed ID: 35673767
[TBL] [Abstract][Full Text] [Related]
49. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
[TBL] [Abstract][Full Text] [Related]
50. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
[TBL] [Abstract][Full Text] [Related]
51. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
Cetinözman F; Jansen PM; Vermeer MH; Willemze R
Arch Dermatol; 2012 Dec; 148(12):1379-85. PubMed ID: 23247480
[TBL] [Abstract][Full Text] [Related]
52. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of atopy and staphylococcal superantigen-specific immunoglobulin E (IgE) antibodies and total serum IgE in primary cutaneous T- and B-cell lymphoma.
Vonderheid EC; Hamilton RG; Kadin ME
J Dermatol; 2019 Dec; 46(12):1170-1178. PubMed ID: 31587349
[TBL] [Abstract][Full Text] [Related]
54. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Olsen E; Vonderheid E; Pimpinelli N; Willemze R; Kim Y; Knobler R; Zackheim H; Duvic M; Estrach T; Lamberg S; Wood G; Dummer R; Ranki A; Burg G; Heald P; Pittelkow M; Bernengo MG; Sterry W; Laroche L; Trautinger F; Whittaker S;
Blood; 2007 Sep; 110(6):1713-22. PubMed ID: 17540844
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.
Alcántara-Hernández M; Torres-Zárate C; Pérez-Montesinos G; Jurado-Santacruz F; Domínguez-Gómez MA; Peniche-Castellanos A; Ferat-Osorio E; Neri N; Nambo MJ; Alvarado-Cabrero I; Moreno-Lafont M; Huerta-Yepez S; Bonifaz LC
Int J Cancer; 2014 May; 134(9):2136-45. PubMed ID: 24127318
[TBL] [Abstract][Full Text] [Related]
56. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
57. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
[No Abstract] [Full Text] [Related]
58. Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature.
Ottevanger R; van Beugen S; Evers AWM; Willemze R; Vermeer MH; Quint KD
J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2377-2387. PubMed ID: 34331819
[TBL] [Abstract][Full Text] [Related]
59. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).
Kim YH; Willemze R; Pimpinelli N; Whittaker S; Olsen EA; Ranki A; Dummer R; Hoppe RT;
Blood; 2007 Jul; 110(2):479-84. PubMed ID: 17339420
[TBL] [Abstract][Full Text] [Related]
60. Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.
Krejsgaard T; Odum N; Geisler C; Wasik MA; Woetmann A
Leukemia; 2012 Mar; 26(3):424-32. PubMed ID: 21904385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]